HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Assessment of the capacity of vehicle cabin air inlet filters to reduce diesel exhaust-induced symptoms in human volunteers.

AbstractBACKGROUND:
Exposure to particulate matter (PM) air pollution especially derived from traffic is associated with increases in cardiorespiratory morbidity and mortality. In this study, we evaluated the ability of novel vehicle cabin air inlet filters to reduce diesel exhaust (DE)-induced symptoms and markers of inflammation in human subjects.
METHODS:
Thirty healthy subjects participated in a randomized double-blind controlled crossover study where they were exposed to filtered air, unfiltered DE and DE filtered through two selected particle filters, one with and one without active charcoal. Exposures lasted for one hour. Symptoms were assessed before and during exposures and lung function was measured before and after each exposure, with inflammation assessed in peripheral blood five hours after exposures. In parallel, PM were collected from unfiltered and filtered DE and assessed for their capacity to drive damaging oxidation reactions in a cell-free model, or promote inflammation in A549 cells.
RESULTS:
The standard particle filter employed in this study reduced PM10 mass concentrations within the exposure chamber by 46%, further reduced to 74% by the inclusion of an active charcoal component. In addition use of the active charcoal filter was associated by a 75% and 50% reduction in NO2 and hydrocarbon concentrations, respectively. As expected, subjects reported more subjective symptoms after exposure to unfiltered DE compared to filtered air, which was significantly reduced by the filter with an active charcoal component. There were no significant changes in lung function after exposures. Similarly diesel exhaust did not elicit significant increases in any of the inflammatory markers examined in the peripheral blood samples 5 hour post-exposure. Whilst the filters reduced chamber particle concentrations, the oxidative activity of the particles themselves, did not change following filtration with either filter. In contrast, diesel exhaust PM passed through the active charcoal combination filter appeared less inflammatory to A549 cells.
CONCLUSIONS:
A cabin air inlet particle filter including an active charcoal component was highly effective in reducing both DE particulate and gaseous components, with reduced exhaust-induced symptoms in healthy volunteers. These data demonstrate the effectiveness of cabin filters to protect subjects travelling in vehicles from diesel exhaust emissions.
AuthorsAla Muala, Maria Sehlstedt, Anne Bion, Camilla Osterlund, Jenny A Bosson, Annelie F Behndig, Jamshid Pourazar, Anders Bucht, Christoffer Boman, Ian S Mudway, Jeremy P Langrish, Stephane Couderc, Anders Blomberg, Thomas Sandström
JournalEnvironmental health : a global access science source (Environ Health) Vol. 13 Issue 1 Pg. 16 (Mar 13 2014) ISSN: 1476-069X [Electronic] England
PMID24621126 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Air Pollutants
  • Hydrocarbons
  • Interleukin-8
  • Irritants
  • Particulate Matter
  • Vehicle Emissions
  • Charcoal
  • Nitric Oxide
  • Nitrogen Dioxide
Topics
  • Adolescent
  • Adult
  • Air Filters
  • Air Pollutants (analysis, toxicity)
  • Air Pollution (adverse effects, analysis, prevention & control)
  • Cell Line, Tumor
  • Charcoal
  • Cross-Over Studies
  • Female
  • Healthy Volunteers
  • Humans
  • Hydrocarbons (analysis, toxicity)
  • Interleukin-8 (immunology)
  • Irritants (analysis, toxicity)
  • Male
  • Motor Vehicles
  • Nitric Oxide (analysis, toxicity)
  • Nitrogen Dioxide (analysis, toxicity)
  • Odorants
  • Particulate Matter (analysis, toxicity)
  • Respiratory Function Tests
  • Taste
  • Vehicle Emissions (analysis, toxicity)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: